|
Diabetes Medication Article
Diabetes Pills
Background Information about Diabetes Pills
Our bodies need glucose as a source of energy for movement, growth, repair, and other functions. When we eat, our bodies break food down into organic compounds, one of which is glucose. But before the cells can use glucose, it must move from the bloodstream into the individual cells. This process requires insulin.
Insulin is produced by the beta cells in the islets of Langerhans in the pancreas. When glucose enters our blood, the pancreas should automatically produce the right amount of insulin to move glucose into our cells. People with type 2 diabetes either produce too little insulin, produce it too late to match the rise in blood glucose, or do not respond correctly to the insulin that is produced. Then glucose builds up in the blood, overflows into the urine, and passes out of the body. This means that the body loses its main source of energy even though the blood contains large amounts of glucose.
Diabetes pills work in one of three ways. They either stimulate the pancreas to release more insulin, increase the body's sensitivity to the insulin that is already present, or slow the breakdown of foods (especially starches) into glucose.
http://www.diabetestestingcenter.com
Mini Med Insulin News
Mini Med Insulin
NEW YORK, Aug 10, 2010 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment ...
Read moreReportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market ... - CNBC
I am back from vacation in Ithaca, New York, and am catching up with my journal reading. The July 22, 2010, lead article in the New England Journal of Medicine immediately caught my eye! "Effectiveness of Sensor ...
Read moreMultiple Daily Insulin Injections vs. the Insulin Pump: Where Are We Now? - HealthCentral.com
It's another David and Goliath story. DexCom ( DXCM ), market cap $700 million, vs. Medtronic ( MDT ), market cap $40 billion. The contest is for the growing market in diabetes management, products that monitor patients ...
Read more